NCT00872833

Brief Summary

Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. People with thalassemia often experience pain, but the exact source of pain remains unknown. This study will examine how pain varies during the blood transfusion cycle in people with thalassemia who are treated with regular blood transfusions.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2009

Geographic Reach
2 countries

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 31, 2009

Completed
3 months until next milestone

Study Start

First participant enrolled

July 1, 2009

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
3.9 years until next milestone

Results Posted

Study results publicly available

August 27, 2014

Completed
Last Updated

October 7, 2015

Status Verified

April 1, 2012

Enrollment Period

1.3 years

First QC Date

March 30, 2009

Results QC Date

April 9, 2014

Last Update Submit

October 5, 2015

Conditions

Keywords

Transfusion-Dependant ThalassemiaPainMild Pain

Outcome Measures

Primary Outcomes (1)

  • Report of Pain by Age Group

    Subjects reported whether or not they had pain (yes/no) during each transfusion cycle (data on up to 3 transfusion cycles were collected for each subject). The percent of subject-cycles with pain was calculated for the quartiles of the transfusion cycle.

    measured daily over the 3 transfusion cycles

Secondary Outcomes (1)

  • Report of Pain by Length of the Transfusion Cycle

    measured daily over the 3 transfusion cycles

Study Arms (2)

age 18-29

People age groups 18-29 with transfusion-dependent thalassemia who have reported at least mild degrees of pain during the main Assessment of Pain study.

age 30+

People age groups 30+ years with transfusion-dependent thalassemia who have reported at least mild degrees of pain during the main Assessment of Pain study.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People with transfusion-dependent thalassemia who receive care at sites funded by the Thalassemia Clinical Research Network and their satellites.

You may qualify if:

  • Participating in the Thalassemia Clinical Research Network Assessment of Pain study
  • Has a transfusion dependence of at least eight transfusions per year
  • Diagnosis of beta thalassemia or E-beta-thalassemia
  • Experiences at least "mild" pain in the 1 month before study entry, as measured by the response to the Brief Pain Inventory (BPI) question #6 from the Assessment of Pain study

You may not qualify if:

  • Unwillingness or inability to complete the Brief Pain Inventory Short Form (BPI-SF) on a daily basis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Children's Hospital of Los Angeles

Los Angeles, California, 90027, United States

Location

Children's Hospital Research Center Oakland

Oakland, California, 94609, United States

Location

Stanford University - School of Medicine

Stanford, California, 94305, United States

Location

Children's Healthcare of Atlanta

Atlanta, Georgia, 30342, United States

Location

Children's Memorial Hospital - Chicago

Chicago, Illinois, 60614, United States

Location

Weill Medical College of Cornell

New York, New York, 10065, United States

Location

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

University Health Network - Toronto General Hospital

Toronto, Ontario, M5G 2C4, Canada

Location

MeSH Terms

Conditions

ThalassemiaPain

Condition Hierarchy (Ancestors)

Anemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Eric Gerstenberger
Organization
New England Research Institutes, Inc.

Study Officials

  • Dru Foote, NP

    Children's Hospital and Research Institute Oakland

    PRINCIPAL INVESTIGATOR
  • Jeanne Boudreaux, MD

    Children's Healthcare of Atlanta

    STUDY CHAIR
  • Thomas Coates, MD

    Children's Hospital Los Angeles

    STUDY CHAIR
  • Elliott Vichinsky, MD

    UCSF Benioff Children's Hospital Oakland

    STUDY CHAIR
  • Michael Jeng, MD

    Stanford University

    STUDY CHAIR
  • Janet Kwiatkowski, MD

    Children's Hospital of Philadelphia

    STUDY CHAIR
  • Nancy Olivieri, MD

    University Health Network - Toronto General Hospital

    STUDY CHAIR
  • Patricia J. Giardina, MD

    Weill Medical College of Cornell

    STUDY CHAIR
  • Brigitta Mueller, MD

    Baylor College of Medicine

    STUDY CHAIR
  • Alexis A. Thompson, MD, MPH

    Ann & Robert H Lurie Children's Hospital of Chicago

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2009

First Posted

March 31, 2009

Study Start

July 1, 2009

Primary Completion

October 1, 2010

Study Completion

October 1, 2010

Last Updated

October 7, 2015

Results First Posted

August 27, 2014

Record last verified: 2012-04

Locations